Advertisement
Advertisement

AMLX

AMLX logo

Amylyx Pharmaceuticals, Inc. Common Stock

22.82
USD
Sponsored
-1.37
-5.66%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

22.59

-0.23
-1.01%

Amylyx Pharmaceuticals, Inc. Common Stock Profile

About

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Joshua B. Cohen

Headquarters

55 Cambridge Parkway, Suite 6W
Cambridge, MA 02142, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.amylyx.com

Auditor

Deloitte & Touche LLP

Share holders

16

Employees

136

Amylyx Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.52B

Enterprise Value

2.47B

Enterprise Value/EBITDA(ttm)

-14.88

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.85

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-50.12%

Return on Invested Capital(ttm)

-54.44%

Return on Assets(ttm)

-46.14%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-165.86M

Net Income Available to Common(ttm)

-152.09M

Diluted EPS(ttm)

-1.43

Share Statistics

Beta (5Y Monthly)

-0.21

52-Week Change

191.07%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

111.42M

Dividend Yield

0.00%

Float4

99.07M

% Held by Insiders

10.90%

% Held by Institutions

95.84%

Balance Sheet

Total Cash(mrq)

250.76M

Total Cash Per Share(mrq)

2.25

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.12%

Quick Ratio(mrq)

17.85%

Book Value Per Share(mrq)

2.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.61

Free Cash Flow(ytd)

-72.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement